Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Residues in plasma

In addition, a number of other assays have been developed for screening antibiotic residues in body fluids of animals at slaughter. They include an agar plate assay for detecting tilmicosin in bovine serum (88), modified CFT and BR-test assays for screening penicillin G residues in plasma of healthy steers (89), a modified CFT for screening plasma and urine samples from healthy market... [Pg.814]

Akagawa M, Sasaki T, Suyama K (2002), Oxidative deamination of lysine residue in plasma protein of diabetic rats. Novel mechanism via the Maillard reaction, Eur. J. Biochem. 269 5451-5458. [Pg.143]

K. Suyama, M. Akagawa, and T. Sasaki, Oxidative deamination of lysine residue in plasma protein from diabetic rat a-dicarbonyl-mediated mechanism, in G, 2002, 243-248. [Pg.176]

Animals. Rapidly metabolized initially by cleavage of the imidazole ring and quantitatively eliminated from the body. Although absorption following dermal exposure is low, residues in plasma and tissues are rapidly eliminated from the body... [Pg.1938]

An assessment of the distribution and depletion of residues in the edible tissues of broilers was complemented with a determination of the concentrations of drug residues in plasma, bile and excreta. Mean plasma radioactivity at 6 hours withdrawal was 0.025 pg/mL and declined below the quantitation limit of 0.009 pg/mL by 24 hours. Bile radioactivity ranged... [Pg.56]

Protein S. Protein S is a single-chain molecule of approximately 78,000 daltons that contains 10 y-carboxy glutamic acid residues in the NH -terminal portion of the molecule. Protein S is a regulatory vitamin K-dependent protein. In plasma 40% of this protein circulates free and 60% circulates bound to C4b binding protein. Free Protein S functions as a nonenzymatic cofactor that promotes the binding of Protein C to membrane surfaces (22—25). [Pg.175]

The NHR contains also the conserved Calcineurin docking site, PxlxIT, required for the physical interaction of NEAT and Calcineurin. Dephosphorylation of at least 13 serines residues in the NHR induces a conformational change that exposes the nuclear localization sequences (NLS), allowing the nuclear translocation of NEAT. Rephosphorylation of these residues unmasks the nuclear export sequences that direct transport back to the cytoplasm. Engagement of receptors such as the antigen receptors in T and B cells is coupled to phospholipase C activation and subsequent production of inositol triphosphate. Increased levels of inositol triphosphate lead to the initial release of intracellular stores of calcium. This early increase of calcium induces opening of the plasma membrane calcium-released-activated-calcium (CRAC) channels,... [Pg.847]

Figure 25-2. The formation and secretion of (A) chylomicrons by an intestinal cell and (B) very low density lipoproteins by a hepatic cell. (RER, rough endoplasmic reticulum SER, smooth endoplasmic reticulum G, Golgi apparatus N, nucleus C, chylomicrons VLDL, very low density lipoproteins E, endothelium SD, space of Disse, containing blood plasma.) Apolipoprotein B, synthesized in the RER, is incorporated into lipoproteins in the SER, the main site of synthesis of triacylglycerol. After addition of carbohydrate residues in G, they are released from the cell by reverse pinocytosis. Chylomicrons pass into the lymphatic system. VLDL are secreted into the space of Disse and then into the hepatic sinusoids through fenestrae in the endothelial lining. Figure 25-2. The formation and secretion of (A) chylomicrons by an intestinal cell and (B) very low density lipoproteins by a hepatic cell. (RER, rough endoplasmic reticulum SER, smooth endoplasmic reticulum G, Golgi apparatus N, nucleus C, chylomicrons VLDL, very low density lipoproteins E, endothelium SD, space of Disse, containing blood plasma.) Apolipoprotein B, synthesized in the RER, is incorporated into lipoproteins in the SER, the main site of synthesis of triacylglycerol. After addition of carbohydrate residues in G, they are released from the cell by reverse pinocytosis. Chylomicrons pass into the lymphatic system. VLDL are secreted into the space of Disse and then into the hepatic sinusoids through fenestrae in the endothelial lining.
A further importance of cysteines lies in the palmitoylation of chemokine receptors. Many chemokine receptors have cysteine residues in their carboxy-terminal regions. In other GPCRs, these have been implicated in palmitoylation and in the anchoring of the carboxy-terminus to the plasma membrane. This effectively generates a fourth intracellular loop in the receptors. Studies on CCR5 have identified a three-cysteine cluster in the carboxy-terminus that is... [Pg.39]

Szathmary and Luhmann [50] described a sensitive and automated gas chromatographic method for the determination of miconazole in plasma samples. Plasma was mixed with internal standard l-[2,4-dichloro-2-(2,3,4-trichlorobenzyloxy) phenethyl]imidazole and 0.1 M sodium hydroxide and extracted with heptane-isoamyl alcohol (197 3) and the drug was back-extracted with 0.05 M sulfuric acid. The aqueous phase was adjusted to pH 10 and extracted with an identical organic phase, which was evaporated to dryness. The residue was dissolved in isopropanol and subjected to gas chromatography on a column (12 m x 0.2 mm) of OV-1 (0.1 pm) at 265 °C, with nitrogen phosphorous detection. Recovery of miconazole was 85% and the calibration graph was rectilinear for 0.25 250 ng/mL. [Pg.45]

Mann and Mitchell [58] described a simple colorimetric method for estimation of (-D)-penicillamine in plasma. Blood containing 2-50 pg of penicillamine was mixed with 0.1 M EDTA solution in tromethamine buffer solution. 0.1 mL of this solution was adjusted to pH 7.4 and centrifuged. To a portion of the plasma was added 3 M HCL, the mixture was freeze-dried, and a suspension of the residue in ethanol was centrifuged. The supernatant liquid was mixed with tromethamine buffer solution (pH 8.2) and 10 mM 5,5 -dithiobis-(2-nitrobenzoic acid) in phosphate buffer solution (pH 7.0), the mixture was shaken with ethyl ether, and the absorbance of the separated aqueous layer was measured at 412 nm. The mean recovery was 60% (four determinations), and the calibration graph was linear for the cited range. [Pg.145]

Contrary to LDL, high-density lipoproteins (HDL) prevent atherosclerosis, and therefore, their plasma levels inversely correlate with the risk of developing coronary artery disease. HDL antiatherogenic activity is apparently due to the removal of cholesterol from peripheral tissues and its transport to the liver for excretion. In addition, HDL acts as antioxidants, inhibiting copper- or endothelial cell-induced LDL oxidation [180], It was found that HDL lipids are oxidized easier than LDL lipids by peroxyl radicals [181]. HDL also protects LDL by the reduction of cholesteryl ester hydroperoxides to corresponding hydroperoxides. During this process, HDL specific methionine residues in apolipoproteins AI and All are oxidized [182]. [Pg.799]

All isoforms of PKC are predominantly localized to the cytosol and, upon activation, undergo translocation to either plasma or nuclear membranes. However, newly synthesized PKCs are localized to the plasmalemma and are in an open conformation in which the auto inhibitory pseudosubstrate sequence is removed from the substrate binding domain. The maturation of PKC isoforms is effected by phosphoinositide-dependentkinase-I (PDK-I), which phosphorylates a conserved threonine residue in the activation loop of the catalytic (C4) domain [24]. This in turn permits the autophosphorylation of C-terminus threonine and serine residues in PKC, a step which is a prerequisite for catalytic activity (see also Chs 22 and 23). The phosphorylated enzyme is then released into the cytosol, where it is maintained in an inactive conformation by the bound pseudosubstrate. It was originally thought that 3-phosphoinositides such as PI(3,4)P2 and PI(3,4,5)P3 could directly activate PKCs. However, it now seems more likely that these lipids serve to activate PDK-1 (a frequent contaminant of PKC preparations). [Pg.357]


See other pages where Residues in plasma is mentioned: [Pg.366]    [Pg.94]    [Pg.139]    [Pg.117]    [Pg.207]    [Pg.366]    [Pg.94]    [Pg.139]    [Pg.117]    [Pg.207]    [Pg.217]    [Pg.528]    [Pg.522]    [Pg.282]    [Pg.96]    [Pg.607]    [Pg.845]    [Pg.202]    [Pg.1025]    [Pg.184]    [Pg.201]    [Pg.582]    [Pg.582]    [Pg.590]    [Pg.601]    [Pg.601]    [Pg.602]    [Pg.197]    [Pg.486]    [Pg.317]    [Pg.692]    [Pg.275]    [Pg.159]    [Pg.465]    [Pg.527]    [Pg.51]    [Pg.529]    [Pg.530]    [Pg.35]    [Pg.303]    [Pg.397]    [Pg.404]   
See also in sourсe #XX -- [ Pg.154 , Pg.155 ]




SEARCH



Residual Stresses in Plasma-Sprayed Hydroxyapatite Coatings

© 2024 chempedia.info